Professor Gabriel Aeppli elected Fellow of the Royal Society
This article was originally published in Scrip
Executive Summary
Professor Gabriel Aeppli has been elected a Fellow of the Royal Society, the UK’s academy of science. The honour acknowledges excellence, thought leadership and innovation across the sector. Professor Aeppli is one of the founding directors of Bio Nano Consulting, which specialises in bio and nanotechnology partnerships between the academic and industrial sectors. He joined University College London in 2002, driving the establishment of the London Centre of Nanotechnology through to its opening in 2006. Professor Aeppli has also won the Néel Medal in 2003, the 2005 Oliver Buckley Prize, the Institute of Physics Mott Medal and Prize in 2008 and the IUPAP Magnetism Prize.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.